Paper: Effect of renal impairment on plasma concentrations of silodosin and its main metabolites in patients with symptoms of benign prostatic hyperplasia (2009 ACCP/ESCP International Congress on Clinical Pharmacy (April 24

Sunday, April 26, 2009

Leonard S. Marks, MD , University of California Los Angeles, Culver City, CA

Marc A. Gittelman, MD , South Florida Medical Research, Aventura, FL

Lawrence A. Hill, PharmD , Watson Laboratories, Salt Lake City, UT

Weining Volinn, MS , Watson Laboratories, Salt Lake City, UT

Gary Hoel, RPh, PhD , Watson Laboratories, Salt Lake City, UT

118 Effect of renal impairment on plasma concentrations of silodosin and its main metabolites in patients with symptoms of benign prostatic hyperplasia